Skip to content
Screener

Omeros OMER Net margin

Discontinued — last reported Q3 '21

Net margin at other companies

Immunome logo
ImmunomeIMNM
-5,593.8%-11,284pp
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
-284.2%+937pp
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
-435.2%-469pp
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
-5,256.8%-14,625pp
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
-4,104.8%-7,304pp
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
-52,939.7%-61,871pp

Other financials

Income statement

See full
Revenue$9.9M—
Gross profit$29.7M—
Operating income-$40.9M-9.2%
Net income$56.1M+268%
EPS (diluted)-$0.59-20.4%

Balance sheet

See full
Cash & equivalents$1.9M-55.3%
Total debt$13.5M-30.3%
Total equity-$63.3M+70.3%
Total assets$286.2M+21.7%

Cash flow

See full
Operating cash flow-$14.5M+59.5%
CapEx--100%
Free cash flow-$14.5M+59.6%

Valuation

See full
Market cap$958.97M+245%
P/S10.7×—

Profitability

See full
Gross margin98.9%—
Operating margin-181.8%—
FCF margin-121.6%—

Returns & leverage

See full
Return on equity86.6%—
Debt / equity0.3×-1.1×
Current ratio3×+1.9×

Where this comes from

Calculated from Omeros’s reported figures.

net income/total revenue=-136.6%

Based on trailing twelve months.

The source filing: Omeros’s 10-Q, filed November 9, 2021. Open the filing →

Filed
Nov 9, 2021, 4:10 PM EST
Fiscal quarter
Q3 FY2021
Calendar quarter
Q3 2021
Accession
0001558370-21-015289

FAQ

What is Omeros's net margin?
Omeros (OMER) reported net margin of -136.6% in Q3 2021.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Ask your AI about Omeros's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude